Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

MeiraGTx Holdings plc - Ordinary Shares (NQ:MGTX)

5.150 -0.470 (-8.36%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 13, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,007,501
Open 5.610
Bid (Size) 5.150 (5)
Ask (Size) 5.400 (21)
Prev. Close 5.620
Today's Range 5.050 - 5.780
52wk Range 3.850 - 8.750
Shares Outstanding 79,418,438
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
MeiraGTx Announces the Presentation of Four Posters at the American Society of Gene and Cell Therapy (ASGCT) 2025 Annual Meeting
Multiple Poster Presentations Highlight the Depth and Novelty of MeiraGTx’s Technology Platforms for Gene and Cell Therapy 
From MeiraGTx
Via GlobeNewswire
MeiraGTx Reports First Quarter 2025 Financial and Operational Results
From MeiraGTx
Via GlobeNewswire

Performance

YTD
-17.9%
-17.9%
1 Month
-6.0%
-6.0%
3 Month
-19.4%
-19.4%
6 Month
-22.7%
-22.7%
1 Year
+0.2%
+0.2%

More News

Read More
MeiraGTx Granted FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for AAV-GAD for the Treatment of Parkinson’s Disease
From MeiraGTx
Via GlobeNewswire
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
There are notable gap-ups and gap-downs in today's session.
Via Chartmill
Crude Oil Falls 1%; Dollar General Posts Upbeat Sales
Via Benzinga
Exposures Fossil Fuels
G-III Apparel Posts Better-Than-Expected Earnings, Joins Ballard Power Systems, Dollar General And Other Big Stocks Moving Higher On Thursday
Via Benzinga
MeiraGTx Collaborates With Hologen AI To Expedite Development Of Parkinson's Candidate, Stock Soars
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
MeiraGTx Reports Fourth Quarter and Full Year 2024 Financial and Operational Results and Recent Business Updates
From MeiraGTx
Via GlobeNewswire
MeiraGTx Enters into a Strategic Collaboration with Hologen AI to Expedite Phase 3 Development of AAV-GAD for Parkinson’s Disease and Industrialize MeiraGTx’s Proprietary Manufacturing Process
From MeiraGTx
Via GlobeNewswire
MeiraGTx Announces The Lancet Publication of Data Demonstrating the Efficacy of rAAV8.hRKp.AIPL1 for the Treatment of Leber Congenital Amaurosis 4 (LCA4) Retinal Dystrophy
From MeiraGTx
Via GlobeNewswire
MeiraGTx Receives Rare Pediatric Disease Designation from FDA for AAV8-RK-RetGC for the Treatment of Patients with Leber Congenital Amaurosis due to GUCY2D Mutations
From MeiraGTx
Via GlobeNewswire
MeiraGTx Granted FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for AAV2-hAQP1 for the Treatment of Grade 2/3 Radiation-Induced Xerostomia
From MeiraGTx
Via GlobeNewswire
MeiraGTx Announces Third Quarter 2024 Financial and Operational Results and Recent Business Updates
From MeiraGTx
Via GlobeNewswire
Jim Cramer: This Tech Stock Is A Buy, SoFi Technologies Is Good
Via Benzinga
MeiraGTx Announces Five Posters at the European Society of Gene and Cell Therapy (ESGCT) 2024 Annual Congress
From MeiraGTx
Via GlobeNewswire
Nasdaq Down 150 Points; Johnson & Johnson Reports Better-Than-Expected Q3 Results
Via Benzinga
Small Cap-MeiraGTx Reveals Encouraging Data From Parkinson's Study Showing Significant, Clinically Meaningful Changes in Key Efficacy Endpoints
Via Benzinga
Crude Oil Tumbles 5%; Goldman Sachs Earnings Top Views
Via Benzinga
Exposures Fossil Fuels
Walgreens Posts Upbeat Earnings, Joins Wolfspeed, Ericsson And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
MeiraGTx Announces Positive Data from Randomized, Sham-controlled Clinical Bridging Study of AAV-GAD for the Treatment of Parkinson’s Disease
From MeiraGTx
Via GlobeNewswire
MeiraGTx Announces Poster Presentation on a Potential Treatment for MC4R Genetic Deficiency at the 2024 Society for Neuroscience Conference
From MeiraGTx
Via GlobeNewswire
MGTX Stock Earnings: MeiraGTx Hldgs Misses EPS, Misses Revenue for Q2 2024
Via InvestorPlace
MeiraGTx Announces $50 Million Offering of Ordinary Shares led by Sanofi and Reports Second Quarter 2024 Financial and Operational Results
From MeiraGTx
Via GlobeNewswire

Frequently Asked Questions

Is MeiraGTx Holdings plc - Ordinary Shares publicly traded?
Yes, MeiraGTx Holdings plc - Ordinary Shares is publicly traded.
What exchange does MeiraGTx Holdings plc - Ordinary Shares trade on?
MeiraGTx Holdings plc - Ordinary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for MeiraGTx Holdings plc - Ordinary Shares?
The ticker symbol for MeiraGTx Holdings plc - Ordinary Shares is MGTX on the Nasdaq Stock Market
What is the current price of MeiraGTx Holdings plc - Ordinary Shares?
The current price of MeiraGTx Holdings plc - Ordinary Shares is 5.150
When was MeiraGTx Holdings plc - Ordinary Shares last traded?
The last trade of MeiraGTx Holdings plc - Ordinary Shares was at 05/13/25 04:00 PM ET
What is the market capitalization of MeiraGTx Holdings plc - Ordinary Shares?
The market capitalization of MeiraGTx Holdings plc - Ordinary Shares is 409.00M
How many shares of MeiraGTx Holdings plc - Ordinary Shares are outstanding?
MeiraGTx Holdings plc - Ordinary Shares has 409M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.